Novel Vaccines to Human Rabies

por Ertl, Hildegund C. J.
Publicado 2009

New Rabies Vaccines for Use in Humans

por Ertl, Hildegund C. J.
Publicado 2019

Adenoviral Vector Vaccines Antigen Transgene

por Ertl, Hildegund C.J.
Publicado 2016

T Cell-Mediated Immune Responses to AAV and AAV Vectors

por Ertl, Hildegund C. J.
Publicado 2021

Immunogenicity and toxicity of AAV gene therapy

por Ertl, Hildegund C. J.
Publicado 2022

Can Viruses be Modified to Achieve Sustained Gene Transfer

por Li, Hua, Ertl, Hildegund C. J.
Publicado 2011

Starved and Asphyxiated: How Can CD8(+) T Cells within a Tumor Microenvironment Prevent Tumor Progression

por Zhang, Ying, Ertl, Hildegund C. J.
Publicado 2016

Depletion of FAP(+) cells reduces immunosuppressive cells and improves metabolism and functions CD8(+)T cells within tumors

por Zhang, Ying, Ertl, Hildegund C.J.
Publicado 2016

Adenoviruses as vaccine vectors

por Tatsis, Nia, Ertl, Hildegund C.J.
Publicado 2004

Pandemic Influenza Vaccines

por DiMenna, Lauren J., Ertl, Hildegund C. J.
Publicado 2009

COVID-19 Vaccines Based on Adenovirus Vectors

por Hasanpourghadi, Mohadeseh, Novikov, Mikhail, Ertl, Hildegund C.J.
Publicado 2021

New human rabies vaccines in the pipeline

por Fooks, Anthony R., Banyard, Ashley C., Ertl, Hildegund C.J.
Publicado 2019

Back to the Future: Can Vaccines Win the Long-Term Fight Against COVID-19?

por Ertl, Hildegund C. J., Currie, Sue L., Livermore, David M.
Publicado 2022

Restricting use of adenovirus vector-based COVID vaccines could endanger public and global health

por Ertl, Hildegund C. J., Currie, Sue L., Luber, Andrew D.
Publicado 2022

Age-related changes in the transcriptome of antibody-secreting cells

por Kannan, Senthil, Dawany, Noor, Kurupati, Raj, Showe, Louise C., Ertl, Hildegund C.J.
Publicado 2016

Survivin-targeting Artificial MicroRNAs Mediated by Adenovirus Suppress Tumor Activity in Cancer Cells and Xenograft Models

por Chi, Yudan, Wang, Xiang, Yang, Yong, Zhang, Chao, Ertl, Hildegund C J, Zhou, Dongming
Publicado 2014

Safety and immunogenicity of a potential checkpoint blockade vaccine for canine melanoma

por Kurupati, Raj K., Zhou, Xiangyang, Xiang, Zhiquan, Keller, Lorraine H., Ertl, Hildegund C. J.
Publicado 2018

2320. Novel checkpoint modifier lowers T cell activation threshold and enhances and broadens vaccine-induced responses to chronic viral infections

por Hasanpourghadi, Mohadeseh, Luber, Andrew, Currie, Sue, Magowan, Colin, Zhou, Xiangyang, Ertl, Hildegund C J
Publicado 2022

Gene Therapy Research at the Frontiers of Viral Immunology

por Hoffman, Brad E., Ertl, Hildegund C. J., Terhorst, Cox, High, Katherine A., Herzog, Roland W.
Publicado 2012

Additional Progress in the Development and Application of a Direct, Rapid Immunohistochemical Test for Rabies Diagnosis

por Rupprecht, Charles E., Xiang, Zhiquan, Servat, Alexandre, Franka, Richard, Kirby, Jordona, Ertl, Hildegund C. J.
Publicado 2018